About Renalytix
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
1460 Broadway, New York, US
|
|
Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney diseases to drive improved patient outcomes and advance value-based care. The Company’s lead product is KidneyIntelX.com, which is being designed to help make significant improvements in kidney health through early risk prognosis and optimal clinical care to reduce the incidence of advanced kidney disease and kidney failure. For more information, visit www.renalytixai.com.
|
Renalytix Email Format
The widely used Renalytix email format is {f}{last}@renalytixai.com (e.g. [email protected]), which is used 75.00% of the time.
| Renalytix Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
75.00%
|
Renalytix Alternatives
Frequently Asked Questions about Renalytix
What is Renalytix email format?
The widely used Renalytix email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
What is Renalytix customer service number?
To contact Renalytix customer service number in your country click here to find.
Search Renalytix Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
